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Objectives: To study the etiology of viral encephalitis (VE) in the children of western Uttar
Pradesh, India and to assess the clinico-epidemiological profile of these children in relation to VE.
Methods: Both cerebrospinal fluid and serum samples were collected from pediatric patients
suffering from encephalitis hospitalized at Jawaharlal Nehru Medical College, Aligarh from July
2004 to November 2006. Viral isolation was done on RD cells, HEp-2 cells, and Vero cells from the
cerebrospinal fluid samples of children with suspected VE. A microneutralization test was per-
formed for enterovirus 71. An enzyme immunoassay for IgM antibodies was performed for measles
virus, mumps virus, varicella zoster virus, herpes simplex virus 1, and Japanese encephalitis virus.
Results: Eighty-seven patients were enrolled in the study. The most common etiology of VE was
enterovirus 71 (42.1%), followed by measles (21.1%), varicella zoster virus (15.8%), herpes simplex
virus (10.5%), and mumps (10.5%). Japanese encephalitis virus was not found in any case.
Enterovirus 71 infection caused significant morbidity in children; mortality occurred in 50%. A
preponderance of cases occurred in December. In our study generalized convulsions along with
altered sensorium were the significant findings in patients with VE.
Conclusions: Enterovirus 71, the major etiology of VE in our study, was associated with significant
mortality and morbidity. Such studies should be conducted frequently to assess the role of
emerging VE in different regions.
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Acute viral encephalitis (VE) is often an unusual manifesta-
tion of common viral infections and most commonly affectsational Society for Infectious Diseases.
e142 F.K. Beig et al.children and young adults; it can lead to considerable mor-
bidity and mortality. Epidemiologic studies estimate the
incidence of VE at 2.5—8.8 per 100 000 persons per year.1,2
However the annual incidence of VE is most likely under-
estimated, especially in developing countries where there
are problems with pathogen detection. Very few studies of VE
have emanated from India, although it can be considered the
epicenter of many emerging viral diseases.
Every day new viruses are being associated with encepha-
litis of varying severity. It would be useful to harbor a strong
clinical suspicion for an unusual viral etiology in cases of both
sporadic as well as epidemics of encephalitis. Japanese B
encephalitis virus (JEV) is an emerging pathogen in North
India and has entrenched itself firmly in the eastern parts of
Uttar Pradesh. This study was undertaken to assess the viral
etiology and epidemiology of acute encephalitis in children in
western Uttar Pradesh. As a microbiological diagnosis of VE is
not always possible in India, we attempted to identify surro-
gate markers for the diagnosis of VE. These included clinical
signs and symptoms, radiological and cytological findings,
seasonal variation, socioeconomic status, and other demo-
graphic variables. No such study has been conducted in this
region, and so far no case of Japanese encephalitis has been
reported from this area.
Materials and methods
This was a prospective cohort study of consecutive patients
with acute febrile encephalopathy syndrome conducted at
the Department of Paediatrics in collaboration with the
Department of Microbiology, Jawaharlal Nehru Medical Col-
lege and Hospital and the Department of Microbiology,
National Institute of Communicable Diseases (NICD) from
July 2004 to November 2006. Patient age varied from 6
months to 12 years. Acute encephalopathy was defined as
fever with alteration of consciousness and/or with neurolo-
gical deficit, secondary to central nervous system involve-
ment lasting more than 24 hours, and not more than a one-
week history. Patients with a different final diagnosis (e.g.,
epilepsy, febrile convulsion, bacterial meningitis, tubercu-
losis, brain tumor, cerebral malaria, or metabolic disorder)
were excluded from the study. Patients were managed symp-
tomatically until a definite cause could be found.
A detailed clinical history was elicited and a rigorous
systemic examination was performed. The outcome was
noted, and any sequelae and residual neurological disability
were observed and categorized. The investigations carried
out were complete blood picture, peripheral smear for
malaria parasite, and blood culture and sensitivity. Cere-
brospinal fluid (CSF) examinations were carried out for viral
isolation and serology, bacterial culture and sensitivity, cytol-
ogy, and blood urea and creatinine. A computed tomography
(CT) scan of the head was done whenever indicated. Both CSF
and serum serology were done for the detection of antibodies
to herpes simplex virus 1 (HSV-1), measles, mumps, varicella
zoster virus (VZV), and JEV. Acute phase serum was used for
the detection of IgM antibodies to enterovirus 71 (EV-71). The
NICD, New Delhi monitors the nationwide etiology of VE and
maintains a national registry of baseline and significant cut-
off titers for serological diagnosis of encephalitis from acute
phase serum. A positive case was defined as one that had a
cut-off well above the baseline titer and varied according tothe virus concerned. In the case of EV-71, on the basis of the
national registry, the baseline titer was 32, while a titer
64 was taken as the positive cut-off.
Specimen collection
Acute phase samples of CSF and serum were collected with
proper aseptic precautions from all patients. CSF was trans-
ported on ice and stored at 70 8C until processed.
Viral isolation
All CSF specimens were inoculated into RD cells, HEp-2 cells,
and Vero cells. Detection of viral growth in the cell lines was
done by the characteristic cytopathic effect of some viruses.
Each tube of recently monolayered cultures was inocu-
lated with 0.2 ml of specimen and incubated in the stationary
sloped position at 36 8C. Observations of cytopathic effect
(CPE) were recorded daily for 4 days. CPE was allowed to
develop until 75% of the cells were affected. Negative cul-
tures were discarded after 14 days.
Viral serology
A microneutralization test was performed for EV-71. IgM
antibodies for HSV-1, measles virus, mumps virus, VZV, and
JEV were estimated by capture ELISA as per the manufac-
turer’s instructions (EIAgen Herpes Simplex Virus IgM kit
supplied by Adaltis, IgM ELISA classic kit supplied by Virion,
Parotite IgM EIA well kit supplied by Radim, Varicella Zoster
kit supplied by Adaltis, and IgM antibody capture ELISA
provided by the National Institute of Virology, Pune, India).
Samples were considered positive for any of the viruses
including HSV-1 when the optical density was above the
cut-off specified by the manufacturer.
Wherever feasible both acute and convalescent sera were
collected from the patient if the initial serological diagnosis
was of EV-71.The background seropositivity of EV-71 is rou-
tinely monitored by the NICD so that distinction of acute from
past infection is not a problem even if a single acute phase
serum sample is tested.
Patient sera were inactivated at 56 8C for 30 min. A 1/8
dilution of each test serum was prepared in serum diluent;
0.025 ml of diluent was added to all wells except row A. A
similar volume was added to another plate for back titration.
Test sera — 2  0.025 ml of 1/8 dilution — were added to row
A only of the test serum plates. Serial two-fold dilutions of
the test sera were made until the serum dilutions ranged
from 1/8 to 1/1024. Virus antigen — 0.025 ml of 100 TCID50
(tissue culture infective dose) — was added to all wells in the
test serum plate. Back titration of the virus was prepared.
The serum plates, virus back titration plates, standard
serum control plates, and the cell control plate were
wrapped in tin foil. These plates were gently shaken to
ensure adequate mixing of the container and then incubated
at 36 8C for 3 h in CO2. Subsequently 0.1 ml of HEp-2 cell
suspension was added to all the plates. They were then
incubated at 36 8C in a CO2 incubator for 5 days.
After 5 days the test was read microscopically and plates
were stained with crystal violet. The presence of stained
cells meant antibody was present or that there was normal
Table 1 Diagnosis of viral etiology
Viral agent causing encephalitis Serology Cell culture
Total positive Positive in CSF Positive in acute serum
Herpes simplex virus 1 2 2 2 0
Varicella zoster virus 3 3 2 0
Measles 4 4 4 0
Mumps 2 2 2 0
Enterovirus 71 8 - 8 0
Japanese encephalitis virus 0 0 0 0
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antibody was absent and that virus grew. The end point of
neutralization was calculated using the Ka¨rber formula, log
50% neutralization titer (log CCID50 (cell culture infective
dose)) = TCID50 = L  d (S  0.5), where L = log of lowest
dilution used in the test, d = difference between log dilution
steps, and S = sum of proportion of positive tests (i.e.,
cultures showing CPE).
The serum dilutions were transcribed into log terms. The
serum antibody titer is the highest dilution of serum that
protects 50% of the cultures against 100 TCID50 of the chal-
lenge virus. Antibody titers were expressed as reciprocals.
Results
The study group comprised a total of 87 patients with a mean
age of 4.35  3.32 years, ranging from 6 months to 12 years.
Themedianagewas 3.5 years and themale to female ratiowas
1.27:1. Almost two thirds of the cases of acuteencephalopathy
(n = 61 (70.1%)) were from Aligarh and the rest were from
neighboring districts. Sixty-four (73.6%) belonged to the lower
socioeconomic class according to the Kuppuswamy scale.3 CSF
and acute serum samples were collected for all these cases.
Convalescent sera were collected from four cases.
A viral etiology was diagnosed in a total of 19 (21.8%) cases
(Figure 1). Among these, the most common etiological agent
identified was EV-71, which was found in eight (42.1%) cases,
followed by measles in four (21.1%), VZV in three (15.8%),
mumps in two (10.5%), and HSV-1 in two (10.5%). In all these
cases the etiology was established by serology (Table 1). No
virus was isolated in the cell lines in this study. EV-71 was
detected bymicroneutralization test. Convalescent sera were
positive in all the four surviving cases infected with EV-71. No
Japanese B encephalitis virus was identified in this region.
A comparison of clinical features with viral etiology is
given in Table 2. Generalized convulsions appeared to beFigure 1 Viral etiology of encephalitis.significantly associated with EV-71, measles, VZV, and HSV.
No other clinical finding was significantly associated with VE.
A skin rash was present in two patients, one with measles and
the other with HSV infection. The other three cases of
measles had a history of rashes when they presented at
our center. Out of the two patients with mumps, one had
neck swelling and both had a history of parotid swelling. The
three patients diagnosed with VZVencephalitis gave a history
of a centripetal distribution of dewdrop-like rashes, which
subsided after a week or so. All three gave a history of
chickenpox within the last 4—5 weeks. Patients diagnosed
with EV-71 and HSV-1 gave non-specific histories. When a
comparison was made between the above viral etiologies,
differences between the epidemiological as well clinical
features of the patients were not found to be statistically
significant ( p-values for age = 0.69, sex = 0.25, and clinical
features = 0.17 (raised intracranial tension), 0.32 (meningeal
signs and skin rashes), and 0.72 (neck swelling and focal
convulsions)).
No diagnosis was possible in 34 (39.1%) cases. These cases
were classified as patients with possible VE. Thus it can be
presumed that there was a total of 53 patients with VE, 19
confirmed and 34 suspected cases.
There was a significant clustering of confirmed cases of VE
in December (n = 13, 68.4%). On comparing the final diagnosis
with socioeconomic status, the lower socioeconomic class
was seen to be significantly associated with VE, p < 0.001.
The mean CSF cell count in the 53 patients was <5  106
cells/l, mean CSF protein was 43.39  33.39 mg/dl, and
mean CSF glucose was 66.21  25.21 mg/dl. No statistical
significance was observed between CSF findings and VE.
A CTscan was done in 25 of the 53 patients with confirmed
and suspected VE; six (17.6%) patients with unknown etiology
had abnormal CT findings, while one case each of EV-71, HSV,
and VZV had abnormal findings as shown in Table 3.
The mean age was lower in the unknown etiology group.
Although death was more common in the unknown etiology
group (35.3%) as compared to the known etiology group
(26.3%), the difference was not statistically significant.
The mortality in children infected with EV-71 was 50%. Con-
valescent sera were available in two cases with EV-71 infec-
tion, which showed a four-fold rise in titers in comparison to
acute phase titers. Sequelae were more common in the
known etiology group (10.5%) as compared to the unknown
etiology group (5.9%) as seen in Table 4. Children with a
Glasgow coma scale (GCS) score >12 had no sequelae, i.e.,
the outcome was good. When the day-to-day progress of
symptoms was recorded, the patients who had a GCS of
>12 on day 1, improved without any sequelae. When the
Table 2 Comparison of clinical features of patients with enterovirus, mumps, measles, herpes simplex virus, and varicella zoster
virus infections
Clinical features Number of cases
EV-71 (n = 8) Mumps (n = 2) Measles (n = 4) HSV (n = 2) VZV (n = 3)
Generalized convulsions 6 (75%) 1 4 (100%) 2 (100%) 3 (100%)
Focal convulsions 1 0 0 0 0
Meningeal signs 0 0 1 0 1
Raised ICT 0 1 1 0 1
Focal deficit 0 0 0 0 0
Cranial nerve palsy 0 0 0 0 1
Skin rashes 0 0 1 1 0
Malaise 0 0 0 0 0
Mild URTI 0 0 0 0 0
Neck swelling 0 1 0 0 0
Mean CSF cellularity, 106/l <5 260 <5 <5 <5
Mean CSF protein, mg/dl 40 60 34 38 48
Mean CSF glucose, mg/dl 68 70 77 80 62
Death 4 0 1 0 0
Sequelae 0 0 0 1 1
EV-71, enterovirus 71; HSV, herpes simplex virus; VZV, varicella zoster virus; ICT, intracranial tension; URTI, upper respiratory tract
infection; CSF, cerebrospinal fluid.
Table 3 Computed tomography features of patients with suspected viral encephalitis
Etiology Normal CT (n = 16) Abnormal CT (n = 9) Abnormal CT finding CT not done (n = 28)
Unknown 11 6 Loss of gray—white differentiation 18
Hypodensity in basal ganglia
Infarcts in fronto-temporal region
Global ischemia with diffuse brain edema
EV-71 3 1 Hypodensities in thalamus and parietal lobes 4
Mumps 2 0 - 1
Measles 0 0 - 3
HSV 0 1 Hypodensity in basal ganglia 2
VZV 0 1 Prominence of temporal horns 0
CT, computed tomography; EV-71, enterovirus 71; HSV, herpes simplex virus; VZV, varicella zoster virus.
Table 4 Comparison of patients with suspected viral encephalitis with known etiology and unknown etiology
Parameter Known viral etiology (n = 19) Unknown viral etiology (n = 34) p-Value
Mean age, years 4.39  3.36 3.34  2.85 0.042
GCS score
<6 8 10 0.026
>6 to <14 7 22
Death
<48 h 3 3 0.003
>48 h 2 9
Sequelae 2 (13.3%) 2 (6.3%) 0.069
GCS, Glasgow coma scale.
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with age, coma scale, and death it was found that the
correlation was statistically significant ( p-values of 0.042,
0.026, and 0.003, respectively). Correlation with respect to
sex was found to be statistically insignificant ( p-value of
0.375).Discussion
The most common etiological agent of VE in our study was EV-
71, which occurred in 42.1% of cases, followed by measles in
21.1% cases, VZV in 15.8%, HSV in 10.5%, andmumps in 10.5%.
JEV was not found in any case.
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phalitis in the USA. Owing to its ubiquitous worldwide dis-
tribution it should represent an important etiology of
encephalitis in India too. However, data pertaining to its
prevalence in India are lacking, thus making its inclusion in
the study essential. Similarly VZV, measles, and mumps are
important causes of encephalitis and their prevalence in this
region is high, making them likely etiological agents of
encephalitis. EV-71 is emerging as an important encephali-
togenic virus. Given the poor sanitation services, overcrowd-
ing, and lack of awareness of good hygiene habits in this area
we felt EV-71 could be an important but little sought for
etiological agent in encephalitis. Since JEV has already
established itself firmly in eastern Uttar Pradesh, surveil-
lance to determine if it is gaining a foothold in western Uttar
Pradesh is absolutely essential.
In a study conducted in Beijing on childhood encephalitis,
enterovirus was most commonly identified (15.4%), followed
by mumps (7.2%), rubella (6.1%), JEV (5.1%), human herpes
virus (2%), and Epstein—Barr virus (1%).4 In contrast, in a Thai
study, dengue virus was identified in a maximum number of
cases, followedbyJEV,HSV,humanherpes virus6, enterovirus,
VZV, and rabies.5 In a European study conducted in Finland,
varicella predominated (25%), followed by mumps, HSV, and
measles.6 In Slovenia, Central European tick-borne encepha-
litis topped the list with 28.8% of cases, followed by VZV (17%),
HSV (10%), rubella (2.9%), mumps (2.3%), andmeasles (1.1%).7
Thusawidevariationexists intheviraletiologicalagentsacross
the globe and even in the same continent. Several factors such
as age, geographic location, season, climate, and host immune
competence affect the epidemiology of VE. Howevermeasles,
mumps, and VZV appear to feature quite prominently in both
Asian and European countries. Interestingly this is despite
effective vaccination programs against mumps, measles,
and rubella in the developed countries.
In our study, a preponderance of cases was noticed in
December (68.4%). A similar variation was observed in a
multicenter study in Finland where most cases occurred from
September to January, with the lowest number seen fromMay
to August.8 However in other studies the highest rate of
infection was seen in summer.4,7 In another study no seasonal
pattern was noticed.5 Thus no clear pattern emerges. How-
ever in the Indian context, the index of suspicion should be
higher in winter.
Generalized convulsions along with altered sensorium
were the significant ‘duo of clinical features’ in our study
in patients with VE. In other studies, focal neurological signs
with alteration of consciousness have been the major find-
ings.2,5 A significant association was noticed among VE
patients with age, GCS, and death. Of the patients with
VE in our study, 32.1% died, which is higher than in other
studies (17%, 1.2%).5,9 The lower rate in these studies may be
due to the higher incidence of VZV encephalitis.
This study used elevated levels of IgM antibodies to HSV-1
as an indicator of herpes simplex encephalitis. Given the poor
Indian population this center caters for, the use of more
expensive and sensitive molecular assays for HSV, like PCR,
was not possible. It is possible that some cases of HSV-1 may
have been missed by the enzyme immunoassay technique.
However, since we detected IgM antibodies to HSV-1 in CSF,
the sensitivity was proportionately higher. In resource-poor
countries serology is still the more cost effective option.Microneutralization testing for EV-71 though time consum-
ing is cheaper than the more sensitive molecular tools. Since
we used both acute and convalescent phase sera, the sensi-
tivity for detection of EV-71 increased. In the cases that
demonstrated a four-fold rise in titer, the evidence for acute
EV-71 is excellent; however in the remaining EV-71 serologic
positive cases, the serologic data are suggestive of EV-71, but
not confirmatory.
Enteroviruses appear to be significant pathogens in the
East as seen in the studies undertaken in Taiwan and China,
as well as in our study.3,10,11 The pathogenesis of EV-71 in
causing encephalitis is not very clear. Some believe that
particularly virulent strains of EV-71 lead to encephalitis
and subsequent mortality. Others believe that it could be a
case of hypersensitivity to EV-71 just like there is in dengue
shock and dengue hemorrhagic syndrome.10 Whatever the
pathogenesis, we need to be aware of its capacity to cause
large epidemics that may lead to death. EV-71 is emerging as
a significant pathogen in this part of the country. It is usually
associated with sporadic VE. In this study too, EV-71 was
sporadic in nature. However it was quite virulent, as 50% of
children infected with EV-71 died. A significant finding in
this infection was generalized convulsions with altered
sensorium.
Herpes simplex encephalitis remains the most common
and important cause of fatal sporadic VE in the industrialized
world.12 However in the Indian as well as Asian context it does
not appear to play a major role.
Japanese encephalitis, although a big public health pro-
blem in eastern Uttar Pradesh, has not made any inroads into
our region of western Uttar Pradesh. However we need to be
extremely vigilant because the primary host and vector are
present in abundance here, not to mention a large suscep-
tible human population. Vector control should be practiced
stringently to prevent the onward march of JEV.
The microbiological diagnosis of VE is usually difficult.
Despite using various cell lines, no virus could be isolated
from the CSF. Similar results were reported in another
study.13 This is the first study of its kind from this region.
EV-71 emerged as the major pathogen in our study. There is a
need for more such studies to further delineate the etiologies
of viral encephalitis.
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